Yinghong Xie

JWA suppresses proliferation in trastuzumab-resistant breast cancer by downregulating CDK12

Yongmei Yin, Junjie Chen, Jianwei Zhou, 2021, Cell death discovery.

HSP90 N‐terminal inhibitors target oncoprotein MORC2 for autophagic degradation and suppress MORC2‐driven breast cancer progression

Da-Qiang Li, Z. Shao, Yi Xiao, 2022, Clinical and translational medicine.

Targeting nucleotide metabolism: a promising approach to enhance cancer immunotherapy

Yizhou Jiang, Y. Gong, P. Ji, 2022, Journal of Hematology & Oncology.

Comprehensive description of the current breast cancer microenvironment advancements via single-cell analysis

Fan Yang, Yongmei Yin, Chunxiao Sun, 2021, Journal of Experimental & Clinical Cancer Research.

JWA suppresses proliferation in trastuzumab-resistant breast cancer by downregulating CDK12

Yongmei Yin, Yan Liang, Wei Li, 2021, Cell Death Discovery.

Discrete functional and mechanistic roles of chromodomain Y-like 2 (CDYL2) transcript variants in breast cancer growth and metastasis

Da-Qiang Li, Z. Shao, Shenglin Huang, 2020, Theranostics.

Inositol monophosphatase 1 (IMPA1) promotes triple‐negative breast cancer progression through regulating mTOR pathway and EMT process

Da-Qiang Li, Fang-Lin Zhang, Yin-Ling Zhang, 2022, Cancer medicine.

Prognostic factors and clinical outcomes of breast cancer patients with disease progression during neoadjuvant systemic therapy

L. Fan, Huai-liang Wu, Guangrong Liu, 2023, Breast.